Deputy Director of SPRI, Cristina Oyón
News 29 October, 2025

The Basque Country strengthens its presence at the European Commission’s Industrial Forum

The Basque Country’s participation in the Industrial Forum demonstrates its commitment to a more innovative, sustainable, and energy-transition-oriented European industry.
-

The Basque Government, through SPRI, took part today in Brussels in the 10th plenary meeting of the Industrial Forum, organized by the Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs of the European Commission, representing the Vanguard Initiative network of European regions. Cristina Oyón, Deputy Director of SPRI, represented the Basque Country at the meeting.

During the session, key strategic issues for the future of European industrial policy were addressed. First, the proposed European Competitiveness Fund (ECF) was discussed — a new budgetary instrument that will allocate €409 billion to support industrial competitiveness, particularly in strategic sectors and SMEs.

The discussions also focused on how to transform the public procurement system into an effective, sustainable investment tool aligned with European objectives. Finally, the “Apply AI” strategy was presented, aimed at accelerating the adoption of artificial intelligence and robotics in European industry, with special emphasis on small and medium-sized enterprises.

The session also introduced the document “Recommendations and Working Principles for the Industrial Forum 2.0”, which outlines proposals for the Forum’s next cycle (2026–2029). The aim is to consolidate this platform as a structured space for dialogue between industry, research, and European institutions — co-designing policies that foster competitiveness, innovation, and industrial growth in Europe.

Key recommendations include:

Recognition of the Forum as a central tool in shaping industrial policies.

Establishment of a work plan with regular meetings and agile consultation mechanisms.

Promotion of active, cross-institutional participation to ensure coherence in industrial policies.

Strengthening of inclusive practices and creation of new thematic working groups.

At the close of the meeting, the organizations CECIMO, EIT Manufacturing, Vanguard Initiative, VTT, and Orgalim, co-signatories of the document, called for the creation of a stronger, more influential Industrial Forum 2.0 with greater impact on the definition of European industrial policies.

Through its participation via SPRI, the Basque Country reaffirms its active role in European debates on the future of industry and its commitment to shaping more innovative and coherent policies aligned with the challenges of industrial transformation.

You can consult the full document HERE.

Related news

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors
18/02/2025 R&D

CIC biomaGUNE launches a company that will transform disease diagnosis by using nanosensors

Taldeki Biosolutions will be developing sensors for rapid, cost-effective, robust antibody detection, thus overcoming the stability and cost problems of current in vitro diagnostics

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions
09/05/2024 R&D

CIC nanoGUNE launches a new call: Industry Collaborative Research Positions

Programa honen helburua da ikertzaile profesionalak tokiko erakundeetan sar daitezen erraztea

Basque Open Industry will show Europe its industrial and technological ecosystem at the European SME Week (SME Week) from 13 to 17 November.
27/09/2023 Digitalisation

Basque Open Industry will show Europe its industrial and technological ecosystem at the European SME Week (SME Week) from 13 to 17 November.

Talent, internationalisation, energy-environmental and technology-digital transitions. SME Week 2023. Exhibition and stands at the BEC: “Rebuild Ukraine”.

Aker Solutions selects TUBACEX as a delivery partner for umbilical tubes for key projects on the Norwegian Continental Shelf

Aker Solutions selects TUBACEX as a delivery partner for umbilical tubes for key projects on the Norwegian Continental Shelf

An order intake for a sum of more than €70 million is one of the most significant deals in the umbilicals market. Solidifying TUBACEX’s technological position as a supplier of advanced industrial solutions for energy and mobility sectors.

‘Syngoi Technologies’:  Columbus VP creates a new company in Bizkaia for synthetic DNA production
01/11/2021 Entrepreneurship

‘Syngoi Technologies’: Columbus VP creates a new company in Bizkaia for synthetic DNA production

Columbus VP, a venture capital investment management company with a singular focus on business opportunities emerging in the biotechnology and life sciences sector.

SPRI Group will propose at the World Manufacturing Forum transformative actions to enhance the presence of women in the manufacturing industry
05/10/2021 Digitalisation

SPRI Group will propose at the World Manufacturing Forum transformative actions to enhance the presence of women in the manufacturing industry

Cristina Oyón has led the international group of experts that has drafted the report that will be disclosed on October 20th and 21st at the World Manufacturing Forum, which can be followed online for free upon registration

The Basque Government  participates  in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN
28/05/2020 Entrepreneurship

The Basque Government participates in the Research and production project for the vaccine against COVID 19, together with Harvard and the company VIRALGEN

Tapia highlights that, once Harvard advances with the vaccine, the Basque Country is ready to take on this opportunity that represents  a unique health, social and business advance

VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)
03/02/2020 Entrepreneurship

VIVEbiotech SL new member of the Board of Directors of the Spanish Bioindustry Association (AseBio)

AseBio brings together more than 730 companies that employ almost 100,000 people and invest more than € 400 million in R&D

VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan
02/10/2019 Entrepreneurship

VIVEbiotech makes a capital increase of 3.5 million euros to complete its expansion plan

in 2021 VIVEbiotech will be able to produce lentiviral vectors for advanced clinical trials

VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office
17/06/2019 Entrepreneurship

VIVEbiotech receives an issue notification of the patent grant for the LENTISOMA technology from the United States Patent and Trademark Office

LENTISOMA is a new generation lentiviral vector whose most outstanding feature is related to the fact that it is not inserted into the genome of cells.

Go to the blog section

Follow us

Specialized channels and daily news on our social profiles.